Covidien
Search results
Find helpful patient information about Medtronic leadless Micra pacemakers for the treatment of bradycardia (slow heartbeat) and MRI safety.
Micra™ AV2 is a leadless pacemaker with automatic AV synchrony to treat patients with bradycardia. This device is delivered percutaneously via a minimally invasive approach and does not require the use of leads. Micra™ AV2 has nearly 16 years of projected median battery life.
The miniaturized Micra™ AV and Micra™ VR* leadless pacemakers are the world's smallest pacemakers 1 for bradyarrhythmia management, delivered percutaneously via a minimally invasive approach and do not require the use of leads.
The Micra™ transcatheter pacing system (TPS) is the world’s smallest pacemaker, 1 delivered percutaneously via a minimally invasive approach, directly into the right ventricle and does not require the use of leads. Download Micra Brochure (opens new window) Indications, Safety, and Warnings (opens new window) Overview.
April 2020. Medtronic data on file. The Micra™ Transcatheter Pacing System (TPS) is delivered percutaneously via a minimally invasive approach, directly into the right ventricle and does not require the use of leads.
Apr 6, 2016 · About the size of one of Mary Lou’s calcium pills, “this new one” was the Medtronic Micra, the world’s smallest pacemaker. In clinical trials at the time of Mary Lou’s procedure, Micra was approved for use in the United States on April 6, 2016.
May 1, 2023 · DUBLIN, May 1, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra™ AV2 and Micra™ VR2, the next generation of its industry-leading miniaturized, leadless pacemakers.
